A novel combination for in vivo breast cancer treatment: TAK1 inhibition combined with metformin and Lentinula edodes compounds synergistically reinvigorates CD8+ T Cells.
Saved in:
| Title: | A novel combination for in vivo breast cancer treatment: TAK1 inhibition combined with metformin and Lentinula edodes compounds synergistically reinvigorates CD8+ T Cells. |
|---|---|
| Authors: | Mahdavi AS; Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran., Bagheri N; Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran., Marincola FM; Translational and Advanced Medicine (TAM) Biosciences, Nashville, TN, USA., Khosravian P; Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran., Ghatrehsamani M; Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, PO Box: 88155-571, Shahrekord, Iran. mahdi.samani.2020@gmail.com. |
| Source: | Journal of translational medicine [J Transl Med] 2026 May 05; Vol. 24 (1). Date of Electronic Publication: 2026 May 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1479-5876 |
|---|---|
| DOI: | 10.1186/s12967-026-07905-9 |
